ATLANTIC CITY, NJ - Opening statements took place Monday in a civil trial against drug manufacturer Merck & Company (NYSE: MRK) involving the widely-prescribed drug Fosamax.
ATLANTIC CITY, NJ - Opening statements are scheduled for March 1st in the second lawsuit to go to trial in state court involving the widely-prescribed drug Fosamax.
Rosenberg v. Merck -- A New Jersey jury this morning found that a Fosamax user did not suffer from osteonecrosis of the jaw (ONJ), and therefore she failed to show that Fosamax caused the harm.
Closing arguments in Rosenberg v. Merck were heard today in Atlantic City, New Jersey. Defense attorney Christy Jones, of Butler Snow, went first.